Cargando…

A Novel Autophagy-Related IncRNAs Signature for Prognostic Prediction and Clinical Value in Patients With Pancreatic Cancer

Autophagy is an important bioprocess throughout the occurrence and development of cancer. However, the role of autophagy-related lncRNAs in pancreatic cancer (PC) remains obscure. In the study, we identified the autophagy-related lncRNAs (ARlncRNAs) and divided the PC patients from The Cancer Genome...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Zhengdong, Li, Xiangyu, Shi, Yuanxin, Lu, Yun, Yao, Wei, Wang, Jianming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769875/
https://www.ncbi.nlm.nih.gov/pubmed/33384999
http://dx.doi.org/10.3389/fcell.2020.606817
_version_ 1783629420592889856
author Deng, Zhengdong
Li, Xiangyu
Shi, Yuanxin
Lu, Yun
Yao, Wei
Wang, Jianming
author_facet Deng, Zhengdong
Li, Xiangyu
Shi, Yuanxin
Lu, Yun
Yao, Wei
Wang, Jianming
author_sort Deng, Zhengdong
collection PubMed
description Autophagy is an important bioprocess throughout the occurrence and development of cancer. However, the role of autophagy-related lncRNAs in pancreatic cancer (PC) remains obscure. In the study, we identified the autophagy-related lncRNAs (ARlncRNAs) and divided the PC patients from The Cancer Genome Atlas into training and validation set. Firstly, we constructed a signature in the training set by the least absolute shrinkage and selection operator penalized cox regression analysis and the multivariate cox regression analysis. Then, we validated the independent prognostic role of the risk signature in both training and validation set with survival analysis, receiver operating characteristic analysis, and Cox regression. The nomogram was established to demonstrate the predictive power of the signature. Moreover, high risk scores were significantly correlated to worse outcomes and severe clinical characteristics. The Pearson’s analysis between risk scores with immune cells infiltration, tumor mutation burden, and the expression level of chemotherapy target molecules indicated that the signature could predict efficacy of immunotherapy and targeted therapy. Next, we constructed an lncRNA–miRNA–mRNA regulatory network and identified several potential small molecule drugs in the Connectivity Map (CMap). What’s more, quantitative real-time PCR (qRT-PCR) analysis showed that serum LINC01559 could serve as a diagnostic biomarker. In vitro analysis showed inhibition of LINC01559 suppressed PC cell proliferation, migration, and invasion. Additionally, silencing LINC01559 suppressed gemcitabine-induced autophagy and promoted the sensitivity of PC cells to gemcitabine. In conclusion, we identified a novel ARlncRNAs signature with valuable clinical utility for reliable prognostic prediction and personalized treatment of PC patients. And inhibition of LINC01559 might be a novel strategy to overcome chemoresistance.
format Online
Article
Text
id pubmed-7769875
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-77698752020-12-30 A Novel Autophagy-Related IncRNAs Signature for Prognostic Prediction and Clinical Value in Patients With Pancreatic Cancer Deng, Zhengdong Li, Xiangyu Shi, Yuanxin Lu, Yun Yao, Wei Wang, Jianming Front Cell Dev Biol Cell and Developmental Biology Autophagy is an important bioprocess throughout the occurrence and development of cancer. However, the role of autophagy-related lncRNAs in pancreatic cancer (PC) remains obscure. In the study, we identified the autophagy-related lncRNAs (ARlncRNAs) and divided the PC patients from The Cancer Genome Atlas into training and validation set. Firstly, we constructed a signature in the training set by the least absolute shrinkage and selection operator penalized cox regression analysis and the multivariate cox regression analysis. Then, we validated the independent prognostic role of the risk signature in both training and validation set with survival analysis, receiver operating characteristic analysis, and Cox regression. The nomogram was established to demonstrate the predictive power of the signature. Moreover, high risk scores were significantly correlated to worse outcomes and severe clinical characteristics. The Pearson’s analysis between risk scores with immune cells infiltration, tumor mutation burden, and the expression level of chemotherapy target molecules indicated that the signature could predict efficacy of immunotherapy and targeted therapy. Next, we constructed an lncRNA–miRNA–mRNA regulatory network and identified several potential small molecule drugs in the Connectivity Map (CMap). What’s more, quantitative real-time PCR (qRT-PCR) analysis showed that serum LINC01559 could serve as a diagnostic biomarker. In vitro analysis showed inhibition of LINC01559 suppressed PC cell proliferation, migration, and invasion. Additionally, silencing LINC01559 suppressed gemcitabine-induced autophagy and promoted the sensitivity of PC cells to gemcitabine. In conclusion, we identified a novel ARlncRNAs signature with valuable clinical utility for reliable prognostic prediction and personalized treatment of PC patients. And inhibition of LINC01559 might be a novel strategy to overcome chemoresistance. Frontiers Media S.A. 2020-12-15 /pmc/articles/PMC7769875/ /pubmed/33384999 http://dx.doi.org/10.3389/fcell.2020.606817 Text en Copyright © 2020 Deng, Li, Shi, Lu, Yao and Wang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cell and Developmental Biology
Deng, Zhengdong
Li, Xiangyu
Shi, Yuanxin
Lu, Yun
Yao, Wei
Wang, Jianming
A Novel Autophagy-Related IncRNAs Signature for Prognostic Prediction and Clinical Value in Patients With Pancreatic Cancer
title A Novel Autophagy-Related IncRNAs Signature for Prognostic Prediction and Clinical Value in Patients With Pancreatic Cancer
title_full A Novel Autophagy-Related IncRNAs Signature for Prognostic Prediction and Clinical Value in Patients With Pancreatic Cancer
title_fullStr A Novel Autophagy-Related IncRNAs Signature for Prognostic Prediction and Clinical Value in Patients With Pancreatic Cancer
title_full_unstemmed A Novel Autophagy-Related IncRNAs Signature for Prognostic Prediction and Clinical Value in Patients With Pancreatic Cancer
title_short A Novel Autophagy-Related IncRNAs Signature for Prognostic Prediction and Clinical Value in Patients With Pancreatic Cancer
title_sort novel autophagy-related incrnas signature for prognostic prediction and clinical value in patients with pancreatic cancer
topic Cell and Developmental Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769875/
https://www.ncbi.nlm.nih.gov/pubmed/33384999
http://dx.doi.org/10.3389/fcell.2020.606817
work_keys_str_mv AT dengzhengdong anovelautophagyrelatedincrnassignatureforprognosticpredictionandclinicalvalueinpatientswithpancreaticcancer
AT lixiangyu anovelautophagyrelatedincrnassignatureforprognosticpredictionandclinicalvalueinpatientswithpancreaticcancer
AT shiyuanxin anovelautophagyrelatedincrnassignatureforprognosticpredictionandclinicalvalueinpatientswithpancreaticcancer
AT luyun anovelautophagyrelatedincrnassignatureforprognosticpredictionandclinicalvalueinpatientswithpancreaticcancer
AT yaowei anovelautophagyrelatedincrnassignatureforprognosticpredictionandclinicalvalueinpatientswithpancreaticcancer
AT wangjianming anovelautophagyrelatedincrnassignatureforprognosticpredictionandclinicalvalueinpatientswithpancreaticcancer
AT dengzhengdong novelautophagyrelatedincrnassignatureforprognosticpredictionandclinicalvalueinpatientswithpancreaticcancer
AT lixiangyu novelautophagyrelatedincrnassignatureforprognosticpredictionandclinicalvalueinpatientswithpancreaticcancer
AT shiyuanxin novelautophagyrelatedincrnassignatureforprognosticpredictionandclinicalvalueinpatientswithpancreaticcancer
AT luyun novelautophagyrelatedincrnassignatureforprognosticpredictionandclinicalvalueinpatientswithpancreaticcancer
AT yaowei novelautophagyrelatedincrnassignatureforprognosticpredictionandclinicalvalueinpatientswithpancreaticcancer
AT wangjianming novelautophagyrelatedincrnassignatureforprognosticpredictionandclinicalvalueinpatientswithpancreaticcancer